by Annie De Groot | Mar 28, 2019 | News
THIS ORIGINAL ARTICLE WAS PUBLISHED IN PR NEWSWIRE. LINK TO THE ORIGINAL ARTICLE CAN BE FOUND HERE. NEW YORK, March 25, 2019 /PRNewswire/ — EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced that its abstract has been selected for...
by Annie De Groot | Mar 5, 2019 | Events
American Association for Cancer Research (AACR) Annual MeetingFriday, March 29th – Wednesday, April 3rdGeorgia World Congress CenterAtlanta, GeorgiaThank you to everyone who attended Dr. Richard’s presentation at AACR 2019. We hope you learned something...
by Sarah Moniz | Jun 13, 2018 | Featured, News
NEW YORK CITY AND PROVIDENCE, RI., June 12, 2018 (BUSINESS WIRE) — EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced the closing of a $1.2M Bridge Financing. The investors include NextWaveBio, Morningside Venture Investments, Accelerate...
by Annie De Groot | Sep 25, 2017 | EpiVax Immunoncology, News
EpiVax Oncology Press Release Sept 25 2017 Sept 25, 2017 (Providence, RI) – EpiVax, Inc., a leader in the fields of immunogenicity assessment, vaccine design, and immune-engineering today announced the launch of EpiVax Oncology Inc., a company focused on the...
by Admin Epivax | Dec 8, 2016 | Events, Thinking Out Loud -Blog
Join us at Biotech Showcase! Partnering opportunities are available! Click Here to schedule. Get leading-edge information on our latest immunoinformatics platform: An Innovative Computational Pipeline for Personalized Cancer Vaccine Design With superior identification...